About 278 Trademarks found for “*RNA”

Pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), human papilloma virus (HPV), respiratory syncytial virus (RSV), hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders and their symptoms; pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; pharmaceutical preparations for the treatment of immunologic diseases and disorders namely, autoimmune diseases and disorders; pharmaceutical preparations for the treatment of atherosclerosis; pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; pharmaceutical preparations for the treatment and prevention of cardiovascular, cardiopulmonary, cardio-renal and renal diseases and disorders; pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis; pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain, bone pain and fatigue; pharmaceutical preparations for the treatment of blood-related diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, sepsis and infections in and of the blood; pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement and osteoarthritis; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and skin structure infections namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and sexually transmitted diseases; pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely hypogonadism, testosterone disorders, androgen disorders and estrogen disorders; pharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders namely irritable bowel disorders and symptoms, digestive disorders and acid-related disorders, namely acidifiers to increase levels of gastric acid to decrease stomach pH for human purposes; pharmaceutical preparations for the treatment of sexual dysfunction namely erectile dysfunction, male and female sexual dysfunction disorders namely arousal disorder, pain disorder, desire disorder and orgasm disorder; pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders; pharmaceutical preparations for the treatment of gynaecological diseases and disorders namely amenorrhoea, dysmenorrheal and infertility; pharmaceutical hormonal preparations namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, vasomotor symptoms, menopausal symptoms, endometriosis, uterine fibroids, Leiomyoma, endourological disorders and for the removal of renal calculi and the treatment of nephrolithiasis and urolithiasis, pre-eclampsia and pre-term labour; pharmaceutical preparations for the treatment of prostatitis, nephritis, cystitis, vaginitis, renal disease; pharmaceutical preparations for the treatment of premenstrual dysphoric disorder, premenstrual syndrome, male hypogonadism and hormonal disorders namely polycystic ovary syndrome; pharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; pharmaceutical preparations for the treatment of alopecia and androgenic alopecia (male pattern baldness); pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; pharmaceutical preparations for the treatment of damaged skin and tissue namely bee stings, sunburn, rashes, sores, corns, calluses and acne; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of malaria; pharmaceutical preparations for the treatment of tuberculosis; allergy medications; vaccines for human use.

Augmented reality software for computer and mobile, downloadable and non-downloadable augmented reality games, namely an amusement game system adapted for use in participating in augmented reality environments in which users can interact for recreational, leisure, education, and entertainment purposes;

Pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), human papilloma virus (HPV), respiratory syncytial virus (RSV), hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders and their symptoms; pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; pharmaceutical preparations for the treatment of immunologic diseases and disorders namely, autoimmune diseases and disorders; pharmaceutical preparations for the treatment of atherosclerosis; pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; pharmaceutical preparations for the treatment and prevention of cardiovascular, cardiopulmonary, cardio-renal and renal diseases and disorders; pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis; pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain, bone pain and fatigue; pharmaceutical preparations for the treatment of blood-related diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, sepsis and infections in and of the blood; pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement and osteoarthritis; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and skin structure infections namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and sexually transmitted diseases; pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely hypogonadism, testosterone disorders, androgen disorders and estrogen disorders; pharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders namely irritable bowel disorders and symptoms, digestive disorders and acid-related disorders, namely acidifiers to increase levels of gastric acid to decrease stomach pH for human purposes; pharmaceutical preparations for the treatment of sexual dysfunction namely erectile dysfunction, male and female sexual dysfunction disorders namely arousal disorder, pain disorder, desire disorder and orgasm disorder; pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders; pharmaceutical preparations for the treatment of gynaecological diseases and disorders namely amenorrhoea, dysmenorrheal and infertility; pharmaceutical hormonal preparations namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, vasomotor symptoms, menopausal symptoms, endometriosis, uterine fibroids, Leiomyoma, endourological disorders and for the removal of renal calculi and the treatment of nephrolithiasis and urolithiasis, pre-eclampsia and pre-term labour; pharmaceutical preparations for the treatment of prostatitis, nephritis, cystitis, vaginitis, renal disease; pharmaceutical preparations for the treatment of premenstrual dysphoric disorder, premenstrual syndrome, male hypogonadism and hormonal disorders namely polycystic ovary syndrome; pharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; pharmaceutical preparations for the treatment of alopecia and androgenic alopecia (male pattern baldness); pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; pharmaceutical preparations for the treatment of damaged skin and tissue namely bee stings, sunburn, rashes, sores, corns, calluses and acne; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of malaria; pharmaceutical preparations for the treatment of tuberculosis; allergy medications; vaccines for human use

Software as a service (SAAS) services featuring software for inventory management, revenue management, supply chain management, customer relationship management, and human resources management in the field of cannabis production, distribution, sales, and regulatory compliance.

Chemical, biological, biochemical and biotechnological products and preparations for industrial and scientific purposes, namely, small molecules in the nature of active chemical ingredients for use in the manufacture of pharmaceuticals, biologics for use in pharmaceuticals, nucleic acids, proteins, lipids, polysaccharides, enzymes, antibodies, stem cells for scientific purposes, culture of bacterial microorganisms for laboratory and scientific research; cultures of bacterial microorganisms for laboratory and scientific research; cultures of microorganisms used in the fermentation of silage; protein-based capsids and particles as well as fragments, fractions and derivatives thereof, for scientific and medical research; active chemicals ingredients for use in the manufacture of anti-cancer drugs; active chemical ingredients for use in the manufacture of pharmaceuticals; active chemical ingredients for use in the manufacture of anti-cancer drugs; protein arrays for diagnosing cancer.

Pharmaceutical preparations, namely, proteins for the treatment and diagnosis of cancer, viral infections and infectious diseases, namely, bacterial skin infections, fungal skin infections, viral skin infections, and parasitic skin infections; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing, namely, testing and detecting of cancer; diagnostic biomarker reagents for medical purposes; diagnostic agents for medical use, namely, tumor markers in the nature of diagnostic biomarkers for use in assessment of cancer biology for medical use; antigens for medical purposes, namely, pharmaceutical preparations for regulating the immune system; diagnostic reagents for medical use; diagnostic agents for pharmaceutical use, namely, diagnostic preparations for clinical laboratory use.

Chemical, biological, biochemical and biotechnological products and preparations for industrial and scientific purposes, namely, small molecules in the nature of active chemical ingredients for use in the manufacture of pharmaceuticals, biologics for use in pharmaceuticals, nucleic acids, proteins, lipids, polysaccharides, enzymes, antibodies, stem cells for scientific purposes, cultures of bacterial microorganisms for laboratory and scientific research; cultures of microorganisms used in the fermentation of silage; protein-based capsids and particles as well as fragments, fractions and derivatives thereof, for scientific and medical research; active chemical ingredients for use in the manufacture of anti-cancer drugs; active chemical ingredients for use in the manufacture of pharmaceuticals; active chemical ingredients for use in the manufacture of insecticides; protein arrays for diagnosing cancer.

Pharmaceutical preparations, namely, proteins for the treatment and diagnosis of cancer, viral infections, and infectious diseases, namely, bacterial skin infections, fungal skin infections, viral skin infections, and parasitic skin infections; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing, namely testing and detecting of cancer; diagnostic biomarker reagents for medical purposes; diagnostic agents for medical use, namely, tumor markers in the nature of diagnostic biomarkers for use in assessment of cancer biology for medical use; antigens for medical purposes, namely, pharmaceutical preparations for regulating the immune system; diagnostic reagents for medical use; diagnostic agents for pharmaceutical use, namely, diagnostic preparations for clinical laboratory use.

Cannabis related products, namely oils, salves, concentrated pastes, tinctures, tablets and capsules, each containing cannabis for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oils, salves, concentrated pastes, tinctures, tablets and capsules each containing resins and oils derived from cannabis for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes containing cannabis for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes containing derivatives of cannabis, namely resins and oils for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; topical skin creams, bar and liquid soaps, bath additives, bath herbs, bath oils, body creams, body oils, face and body lotions, face and body milk, face lotion, and skin care preparations each containing derivatives of cannabis, for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; personal sexual lubricants; transdermal patches containing cannabis for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oral sprays containing cannabis for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; cannabis and marijuana for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; cannabis related product, namely, oils for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oils derived from cannabis for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy

Oils and resins derived from cannabis, for use as comestibles; cannabis related product, namely, oils for use as comestibles; oils derived from cannabis for use as comestibles; food products containing cannabis, cannabis resins and cannabis oils, namely butter

Vaccines for human use.

Biochemicals, namely, protein-encoding nucleic acids and polypeptide-encoding nucleic acids for in vivo, ex vivo, on vivo or in vitro scientific research and medical research; biochemicals, namely, protein-encoding nucleic acids and polypeptide-encoding nucleic acids for use in the manufacture of pharmaceuticals for treating cancers, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders; reagents for testing sterility of pharmaceuticals; diagnostic reagents for medical-scientific research use; chemicals for use in biotherapeutics, and therapeutics product development and manufacturing processes; polypeptide encoding nucleic acids for laboratory use.

Medical, biological and pharmaceutical preparations for scientific, research, medical, or pharmaceutical use, namely, preparations for treating cancers, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders; medical, biological and pharmaceutical preparations containing polypeptide encoding nucleic acids for the prevention and treatment of cancers, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders, and the prevention and treatment of rare diseases, namely, Cystic fibrosis, Methylmalonic acidemia, Propionic acidemia, Phenylketonuria, Ornithine transcarbamylase deficiency, Maple syrup urine disease, Arginase-1 deficiency, Factor VIII deficiency, Glycogen storage disorder type 1a, Adult-onset type II citrullinemia and Progressive familial intrahepatic cholestasis type; RNA-based therapeutics and therapeutic agents for in vitro preparation and in vivo, ex vivo, or on vivo delivery to cell sites; medical diagnostic reagents.

Biochemicals, namely, protein-encoding nucleic acids and polypeptide-encoding nucleic acids for in vivo, ex vivo, on vivo or in vitro scientific research and medical research; biochemicals, namely, protein-encoding nucleic acids and polypeptide-encoding nucleic acids for use in the manufacture of pharmaceuticals for treating cancers, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious; reagents for testing sterility of pharmaceuticals; diagnostic reagents for medical-scientific or research use; in vitro diagnostic reagents for scientific use and medical-scientific research use; in vitro diagnostic reagents for scientific purposes; chemicals for use in biotherapeutics, and therapeutics product development and manufacturing processes; polypeptide encoding nucleic acids for laboratory use.

Medical, biological and pharmaceutical preparations for scientific, research, medical, or pharmaceutical use, namely, preparations for preventing and treating cancers, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders; ¿ medical, biological and pharmaceutical preparations containing polypeptide encoding nucleic acids for preventing and treating cancers, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders, and for preventing and treating rare diseases, namely, Cystic fibrosis, Methylmalonic acidemia, Propionic acidemia, Phenylketonuria, Ornithine transcarbamylase deficiency, Maple syrup urine disease, Arginase-1 deficiency, Factor VIII deficiency, Glycogen storage disorder type 1a, Adult-onset type II citrullinemia and Progressive familial intrahepatic cholestasis type; RNA-based therapeutics and therapeutic agents for in vitro preparation and in vivo, ex vivo, or on vivo delivery to cell sites; medical diagnostic reagents.